K.-H. Schlingensiepen
- Genetics top 5%
- Glioma Diagnosis and Treatment 13
- Oncology top 10%
- Cancer Cells and Metastasis 7
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Cytokine Signaling Pathways and Interactions 4
-
- TGF-β signaling in diseases 11
-
- Cancer Research and Treatments 8
-
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- W. BryschPiotr JachimczakUlrich BogdahnReimar SchlingensiepenH. HeinrichsPeter HauВ. Е. ПарфеновO. Creutzfeldt
- Partner nations
- GermanyIndiaUnited States
In The Last Decade
K.-H. Schlingensiepen
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 83
- Endocrine and Autonomic Systems 138
- Genetics 194
- Oncology 365
- Cellular and Molecular Neuroscience 201
- Molecular Biology 560
Countries citing papers authored by K.-H. Schlingensiepen
This map shows the geographic impact of K.-H. Schlingensiepen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-H. Schlingensiepen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-H. Schlingensiepen more than expected).
Fields of papers citing papers by K.-H. Schlingensiepen
This network shows the impact of papers produced by K.-H. Schlingensiepen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-H. Schlingensiepen. The network helps show where K.-H. Schlingensiepen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K.-H. Schlingensiepen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 331 | |
| 2 | 2009 | 7 | |
| 3 | 2008 | 6 | |
| 4 | 2007 | 2 | |
| 5 | 2004 | 24 | |
| 6 | 2004 | 13 | |
| 7 | 2004 | 4 | |
| 8 | 2000 | 8 | |
| 9 | Antisense : from technology to therapy : lab manual and textbook | 1997 | 15 |
| 10 | Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice. | 1996 | 55 |
| 11 | 1995 | 158 | |
| 12 | Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. | 1994 | 27 |
| 13 | 1994 | 45 | |
| 14 | 1993 | 113 | |
| 15 | 1993 | 10 | |
| 16 | DIFFERENTIAL EXPRESSION OF PROTOONCOGENES AND HEAT-SHOCK PROTEINS DURING LEARNING AND MEMORY FORMATION IN RAT-BRAIN | 1992 | 0 |
| 17 | 1991 | 72 | |
| 18 | Synthesis and ultrastructural distribution of ependymins in goldfish brain analyzed by insitu hybridezation and immonugold labeling | 1990 | 1 |
| 19 | 1990 | 24 | |
| 20 | 1990 | 8 |
About K.-H. Schlingensiepen
K.-H. Schlingensiepen is a scholar working on Genetics, Biotechnology and Cancer Research, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (13 papers), TGF-β signaling in diseases (11 papers), Cancer Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer Cells and Metastasis (7 papers), Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (138 citations), Genetics (194 citations) and Oncology (365 citations). K.-H. Schlingensiepen has collaborated with scholars based in Germany, India and United States. Frequent co-authors include W. Brysch, Piotr Jachimczak, Ulrich Bogdahn, Reimar Schlingensiepen, H. Heinrichs, Peter Hau, В. Е. Парфенов, O. Creutzfeldt, S. Schmaus and Franziska Wollnik.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.